IL80950A - Skin patch for transdermal administration of oxazoloazepine and thiazoloazepine derivatives and its preparation - Google Patents

Skin patch for transdermal administration of oxazoloazepine and thiazoloazepine derivatives and its preparation

Info

Publication number
IL80950A
IL80950A IL80950A IL8095086A IL80950A IL 80950 A IL80950 A IL 80950A IL 80950 A IL80950 A IL 80950A IL 8095086 A IL8095086 A IL 8095086A IL 80950 A IL80950 A IL 80950A
Authority
IL
Israel
Prior art keywords
oxazoloazepine
thiazoloazepine
derivatives
preparation
transdermal administration
Prior art date
Application number
IL80950A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of IL80950A publication Critical patent/IL80950A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL80950A 1985-12-14 1986-12-12 Skin patch for transdermal administration of oxazoloazepine and thiazoloazepine derivatives and its preparation IL80950A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3544311 1985-12-14

Publications (1)

Publication Number Publication Date
IL80950A true IL80950A (en) 1991-05-12

Family

ID=6288476

Family Applications (1)

Application Number Title Priority Date Filing Date
IL80950A IL80950A (en) 1985-12-14 1986-12-12 Skin patch for transdermal administration of oxazoloazepine and thiazoloazepine derivatives and its preparation

Country Status (13)

Country Link
US (1) US4826686A (fi)
EP (1) EP0227988A3 (fi)
JP (1) JPS62148422A (fi)
KR (1) KR870006054A (fi)
AU (1) AU593863B2 (fi)
CA (1) CA1291039C (fi)
DK (1) DK599986A (fi)
FI (1) FI865069A (fi)
IL (1) IL80950A (fi)
NO (1) NO865028L (fi)
NZ (1) NZ218616A (fi)
PT (1) PT83919B (fi)
ZA (1) ZA869373B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
WO1991015176A1 (en) * 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
US5498417A (en) * 1994-05-12 1996-03-12 Coating Sciences, Inc. Transdermal delivery of appetite suppressant drug
US5543133A (en) * 1995-02-14 1996-08-06 Nanosystems L.L.C. Process of preparing x-ray contrast compositions containing nanoparticles
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
ITPD20020138A1 (it) * 2002-05-24 2003-11-24 Matteo Bevilacqua Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
JP5137286B2 (ja) * 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤
JP4924837B2 (ja) * 2005-04-20 2012-04-25 千寿製薬株式会社 経皮吸収製剤
WO2008001204A2 (en) * 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal compositions of pramipexole having enhanced permeation properties

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2040510C3 (de) * 1970-08-14 1980-03-06 Dr. Karl Thomae Gmbh, 7950 Biberach Oxazole- und Thiazole eckige Klammer auf 5,4-d] azepin- Derivate
BG17968A3 (bg) * 1970-08-14 1974-03-05 Dr. Karl Thomae Gmbh Метод за получаване на производни на азепина
DE2836387A1 (de) * 1978-08-19 1980-02-28 Boehringer Sohn Ingelheim Retardform fuer einen blutdrucksenkenden und antanginoes wirkenden stoff
JPS56133381A (en) * 1980-03-25 1981-10-19 Nippon Kayaku Co Ltd Pressure-sensitive adhesive tape or sheet containing nitroglycerin
AU553343B2 (en) * 1981-08-10 1986-07-10 Advance Electrode Kabushikikaisya Absorbent adhesive bandage with medicament release
US4400378A (en) * 1981-11-02 1983-08-23 Karl Thomae Gesellschaft Mit Beschrankter Haftung Pharmaceutical composition for the treatment of glaucoma
DE3204551A1 (de) * 1982-02-10 1983-08-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung einer pharmazeutischen zubereitung in form eines polyacrylat-films
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
DE3428342A1 (de) * 1984-08-01 1986-02-13 Boehringer Ingelheim Vetmedica GmbH, 6507 Ingelheim Futtermittelzusatz zur verbesserung des wachstums bei landwirtschaftlichen nutztieren
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device

Also Published As

Publication number Publication date
FI865069A (fi) 1987-06-15
NZ218616A (en) 1990-02-26
PT83919B (pt) 1989-05-12
PT83919A (en) 1987-01-01
US4826686A (en) 1989-05-02
EP0227988A3 (de) 1990-04-11
CA1291039C (en) 1991-10-22
NO865028D0 (no) 1986-12-12
JPS62148422A (ja) 1987-07-02
DK599986A (da) 1987-06-15
AU593863B2 (en) 1990-02-22
FI865069A0 (fi) 1986-12-12
KR870006054A (ko) 1987-07-09
EP0227988A2 (de) 1987-07-08
NO865028L (no) 1987-06-15
ZA869373B (en) 1988-08-31
DK599986D0 (da) 1986-12-12
AU6645086A (en) 1987-06-18

Similar Documents

Publication Publication Date Title
US4588580B2 (en) Transdermal administration of fentanyl and device therefor
GB2199031B (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
GB8609219D0 (en) Transdermal delivery of drugs
IL82192A0 (en) System for administration of drugs to the skin and process for the preparation thereof
CS39586A3 (en) Peptide derivatives, process of their preparation and use
GB2184019B (en) Multicompartmentalized dermal and transdermal patches
PH25897A (en) Anti-inflammatory skin moisturizing composition and method of preparing same
GB2181346B (en) Pharmaceutical compositions and medical uses of dioxopiperidine derivatives
HK1005592A1 (en) Benzimidazole derivatives process for their preparation and therapeutic application
GB2192134B (en) Transdermal delivery of drugs
GR860849B (en) 4-demethyl -4- epipodophyllotoxin derivatives process for their preparation and their use as medicaments
GB2215208B (en) Transdermal administration of plant extracts
IL80950A (en) Skin patch for transdermal administration of oxazoloazepine and thiazoloazepine derivatives and its preparation
GB2256588B8 (en) Preparation for transdermal administration of procaterol
ZA867839B (en) Biologically active derivatives of human ypsilon-interferon
GR862211B (en) Azolyl-cyclopropyl-ethanol derivatives methods for their preparation and their use
AU5541886A (en) Method of administering ethanolamine derivatives to livestock
IL80307A0 (en) Preparation of phenylpropanone derivatives
ZA879452B (en) 5-hydroxyethyl derivatives of oxazolidinone-2,their preparation and their therapeutic uses
AU4968585A (en) Physiological means of enhancing transdermal delivery of drugs
GB2179656B (en) Preparation of indole and indole derivatives
IL79438A0 (en) Preparation of 2-cyanoaminopyrimidine derivatives
HK1005735A1 (en) Perhydrothiazepine and perhydroazepine derivatives their preparation and their therapeutic use
AR242386A1 (es) Procedimiento para la preparacion de los estereoisomeros trans de derivados de eburnamenina, opticamente activos.
GB2159714B (en) Pharmaceutical composition of sparingly soluble medicament and method for its preparation